Implantation or Injectable Dosage Form New Animal Drugs; Erythromycin
other · Food and Drug Administration · Rule · Published 2007-12-07 · Effective 2007-12-07 · 72 FR 69142
Document
Document number
E7-23763
Federal Register citation
72 FR 69142
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2007-12-07
Effective date
2007-12-07
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Cross Vetpharm Group Ltd. The supplemental NADA provides for use of a 100 milligram per milliliter (mg/mL) strength erythromycin injectable solution in cattle for the treatment of bovine respiratory disease.